Acute glucose deprivation leads to apoptosis in a cell model of acute diabetic neuropathy

Journal of the Peripheral Nervous System

Volumn 8, Issue 2, 2003, Pages 65-74

  Honma, Hiroyuki ^a   Podratz, Jewel L ^a   Windebank, Anthony J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Apoptosis; Diabetic neuropathy; Glucose

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CELL DNA; GLUCOSE; NERVE GROWTH FACTOR; THIOCTIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; DIABETIC NEUROPATHY; DNA DEGRADATION; EMBRYO; GLUCOSE METABOLISM; IMMUNOCYTOCHEMISTRY; NERVE CELL NECROSIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BENZAMIDES; CASPASE 3; CASPASES; CELL COUNT; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; GANGLIA, SPINAL; GLUCOSE; IMIDES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON; NERVE GROWTH FACTOR; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; THIOCTIC ACID; TIME FACTORS;

EID: 0041784076     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8027.2003.03009.x     Document Type: Article

References (44)

1. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV (1996). The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 2:703-707.
2. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA (1994). Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 634:7-12.
3. Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA (1998). Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 51:695-702.
4. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J (1983). The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 46:491-499.
5. Asbury AK, Fields HL (1984). Pain due to peripheral nerve damage: an hypothesis. Neurology 34:1587-1590.
6. Bravenboer B, Kappelle AC, Hamers FP, van Buren T, Erkelens DW, Gispen WH (1992). Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 35:813-817.
7. Britland ST, Young RJ, Sharma AK, Clarke BF (1992). Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology. Pain 48:361-370.
8. Cameron NE, Cotter MA, Low PA (1991). Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261:E1-E8.
9. Caravati CM (1933). Insulin neuritis: a case report. Virginia M Monthly 59:745-746.
10. Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986.
11. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E (1995). In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6:1053-1057.
12. Ellenberg M (1974). Diabetic neuropathic cachexia. Diabetes 23:418-423.
13. Feldman EL, Stevens MJ, Greene DA (1997). Pathogenesis of diabetic neuropathy. Clin Neurosci 4:365-370.
14. Gao WQ, Dybdal N, Shinsky N, MurnaneA, Schmelzer C, Siegel M, Keller G, Hefti F, Phillips HS, Winslow JW (1995). Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 38:30-37.
15. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA (1992). Complications: neuropathy, pathogenetic considerations. Diabetes Care 15:1902-1925.
16. Hermenegildo C, Raya A, Roma J, Romero FJ (1993). Decreased glutathione peroxidase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels. Neurochem Res 18:893-896.
17. Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR (1995). Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats: comparison with essential fatty acids. Diabetologia 38:129-134.
18. Kerr JF, Winterford CM, Harmon BV (1994). Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013-2026.
19. Llewelyn JG, Thomas PK, Fonseca V, King RHM, Dandona P (1986). Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol 72:157-163.
20. Low PA (1987). Recent advances in the pathogenesis of diabetic neuropathy. Muscle Nerve 10:121-128.
21. Low PA, Nickander KK, Tritschler HJ (1997). The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46:S38-S42.
22. Matthews CC, Feldman EL (1996). Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 166:323-331.
23. Matthews CC, Odeh HM, Feldman EL (1997). Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience 79:525-534.
24. Nagamatsu M, Nickander KK, Schmeizer JD, Raya A, Wittrock DA, Tritschler H, Low PA (1995). Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167.
25. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJ, Ward JD (1986). Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) 293:1053-1054.
26. Nickander KK, McPhee BR, Low PA, Tritschler H (1996). Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 21:631-639.
27. Nickander KK, Schmelzer JD, Rohwer DA, Low PA (1994). Effect of alpha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J Neurol Sci 126:6-14.
28. Oudega M, Hagg T (1999). Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord. Brain Res 818:431-438.
29. Pirart J (1978). Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1:168-188.
30. Root HF, Rogers MH (1930). Diabetic neuritis with paralysis. N Engl J Med 202:1049-1053.
31. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL (1999). Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6:347-363.
32. Santos X, Rodrigo J, Hontanilla B, Bilbao G (1999). Local administration of neurotrophic growth factor in subcutaneous silicon chambers enhances the regeneration of the sensory component of the rat sciatic nerve. Microsurgery 19:275-280.
33. Sasaki H, Schmelzer JD, Zollman PJ, Low PA (1997). Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol (Berl) 93:118-128.
34. Singleton JR, Dixit VM, Feldman EL (1996a). Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 271:31791-31794.
35. Singleton JR, Randolph AE, Feldman EL (1996b). Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res 56:4522-4529.
36. Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994). Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-2533.
37. Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, Ward JD (1996). Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 39:329-335.
38. Tompkins MM, Basgall EJ, Zamrini E, Hill WD (1997). Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am J Pathol 150:119-131.
39. Troost D, Aten J, Morsink F, de Jong JM (1995). Apoptosis in ALS is not restricted to motoneurons: Bcl-2 expression is increased in post-central cortex, adjacent to the affected motor cortex. J Neurol Sci 129:79-80.
40. Tuck RR, Schmelzer JD, Low PA (1984). Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107:935-950.
41. Windebank AJ, Feldman EL (2001). Diabetes and the nervous system. In: Neurology and General Medicine. Aminoff MJ (Ed). Churchill Livingstone, New York, pp 341-364.
42. Yoshiyama Y, Yamada T, Asanuma K, Asahi T (1994). Apoptosis related antigen, Le (Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol 88:207-211.
43. Zheng JL, Stewart RR, Gao WQ (1995a). Neurotrophin-4/5, brain-derived neurotrophic factor, and neurotrophin-3 promote survival of cultured vestibular ganglion neurons and protect them against neurotoxicity of ototoxins. J Neurobiol 28:330-340.
44. Zheng JL, Stewart RR, Gao WQ (1995b). Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity. J Neurosci 15:5079-5087.